Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01014403 · ClinicalTrials.gov registry record · Phase 1
Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)
A Phase 1 study, sponsored by University of Texas Southwestern Medical Center.
- Completed
- Registry status
- Phase 1
- Development phase
- 62
- Enrollment target
NCT01014403 is a Phase 1 study that has completed, run by University of Texas Southwestern Medical Center. The registered enrollment target is 62 participants.
The verdict
NCT01014403, a Phase 1 study, has completed, sponsored by University of Texas Southwestern Medical Center.
- COMPLETED
- Registry status
- Phase 1
- Development phase
- 62 participants
- Enrollment target
Study Summary
Brain injured patients are at high risk for forming blood clots in the legs and lungs. For non-brain injured trauma patients, we decrease the chances of these blood clots forming by placing the patients on a low dose of the blood thinner enoxaparin. Starting patients with a brain injury on the blood thinner is problematic, however, as this can theoretically cause the brain injury to worsen. Trauma surgeons wait a variable period of time before starting this blood thinner because waiting too long can result in the formation of these blood clots in the legs and lungs. Previous research has shown that some brain injuries which are of lower severity can have enoxaparin started at 24 hours after injury if the brain injury is stable on a repeated computed tomography (CT) scan of the head. This is a pilot study designed to look at the rates of worsening of brain injury if the low dose blood thinner is started at 24 versus 96 hours post-injury.
Interventions
- DRUG placebo
- DRUG enoxaparin
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 62 participants |
| Start Date | 2009-11 |
| Est. Completion | 2011-05 |
| Phase | Phase 1 |
Interested in This Trial?
Full Details on ClinicalTrials.gov ↗What the Registry Record Tells You About NCT01014403
The ClinicalTrials.gov registry entry for NCT01014403 describes a study currently listed as completed, categorized as Phase 1. The registered enrollment target is 62 participants, a figure that helps gauge the scale of data the investigators plan to collect. The listed sponsor is University of Texas Southwestern Medical Center, which has 837 total studies on file at ClinicalTrials.gov.
The record links to 0 conditions, and to 2 interventions - of which placebo is the first listed.
NCT01014403 reports 0 study locations.
Frequently Asked Questions
What is clinical trial NCT01014403 about?
NCT01014403 is a clinical study titled "Delayed Versus Early Enoxaparin Prophylaxis After Traumatic Brain Injury (TBI)". Brain injured patients are at high risk for forming blood clots in the legs and lungs. For non-brain injured trauma patients, we decrease the chances of these blood clots forming by placing the patients on a low dose of the blood thinner enoxaparin. Starting patients with a brain injury on the blood...
What is the current status of trial NCT01014403?
This trial is currently completed. It is a Phase 1 study. The enrollment target is 62 participants. The study started on 2009-11. Estimated completion is 2011-05.
What interventions are being tested in trial NCT01014403?
The interventions under investigation include: placebo (DRUG), enoxaparin (DRUG).
Who is sponsoring clinical trial NCT01014403?
This trial is sponsored by University of Texas Southwestern Medical Center, which has 837 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Explore more on PlainTrial
Read our methodology - how this data is sourced, computed, and verified.
Related
Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.